U.S. label record^↗Metabolic^↗

Insulin glargine-aldy^↗

Related names in cited records: Langlara^↗

A long-acting insulin analogue. This profile cites a U.S. prescription label.^↗

Citation markers ↗ open the public records supporting the adjacent statements.

Profile update · July 27, 2026

We rewrote the profile summary to describe the cited public record more directly. The cited sources and status did not change. ¹

This version supersedes public version 1.

Evidence summary

What the cited records say

The cited DailyMed label identifies Insulin glargine-aldy and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.^↗

This is a source summary, not a medical recommendation. Status may differ by jurisdiction and product.

Cited context

Related records

Organizations named in cited records

U.S. National Library of Medicine^↗

Dated source history

Updates connected to this profile

No dated update is published for this profile. PeptideScanner does not monitor every source continuously; the current profile summary and cited records remain available below.